TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 30 filers reported holding TSCAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,163,000 | – | 139,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $5,254,000 | 20.63% |
| Deer IX & Co. Ltd. | 1,245,505 | $9,349,000 | 0.96% |
| DC Investments Management, LLC | 35,563 | $297,000 | 0.55% |
| Alphabet Inc. | 1,077,080 | $8,983,000 | 0.21% |
| Monashee Investment Management LLC | 100,000 | $834,000 | 0.15% |
| RA Capital Management | 1,255,317 | $10,469,000 | 0.14% |
| HHLR ADVISORS, LTD. | 1,282,976 | $10,700,000 | 0.14% |
| Tekla Capital Management LLC | 200,000 | $1,668,000 | 0.05% |
| Baker Brothers Advisors | 1,425,000 | $11,885,000 | 0.05% |
| CAAS CAPITAL MANAGEMENT LP | 75,000 | $626,000 | 0.01% |